01—Abstract
Summary
Summary of the 10-K filed February 25, 2021. Cited figures are marked; the original filing is the authoritative source.
IDEX Corporation's 2020 Form 10-K reports net sales of $2.35 billiona, down 6% from $2.49 billion in 2019, with organic sales down 9%, partially offset by a 3% increase from acquisitions (Flow MD and Velcora).
Operating income fell 10% to $520.7 millionb, and operating margin declined to 22.1% from 23.2%. Net income decreased 11% to $377.8 million, and diluted EPS was $4.94 versus $5.56. Adjusted EPS, which excludes restructuring, inventory step-up, and debt redemption charges, was $5.19 compared with $5.80.
Management attributes the declines mainly to COVID-19, with end markets improving from the third quarter of 2020 through the fourth quarter. Cash flow from operations rose 7.8% to $569.3 millionc, supported by working capital performance. The company ended the year with $1,025.9 million of cash and cash equivalents and an $792.8 million net available borrowing capacity under its revolving facility.
It issued $500.0 milliond of 3.0% Senior Notes due 2030 and redeemed $300.0 million of 4.5% Senior Notes. Total borrowings were $1,050.2 million, all fixed rate, and the company reported compliance with its financial covenants. Share repurchase authorization remaining was $712.0 million.
Subsequent to year end, IDEX agreed on January 8, 2021 to acquire Abel Pumps, L.P. and certain affiliates for $103.5 million in cash, expected to close by the end of the first quarter of 2021, subject to regulatory approval. The filing also reports that the company has three reportable segments and 13 platforms, and that its internal control over financial reporting was effective as of December 31, 2020.
02—Key points
Key Highlights
- Net sales were $2,351.6 million in 2020, down 6% from $2,494.6 million in 2019; organic sales declined 9%.
- Operating income was $520.7 million, down 10%, with operating margin of 22.1% versus 23.2% in 2019.
- Diluted EPS was $4.94 versus $5.56 in 2019; adjusted EPS was $5.19 versus $5.80.
- Operating cash flow rose to $569.3 million, and cash and cash equivalents reached $1,025.9 million at year end.
- The company issued $500.0 million of 3.0% Senior Notes due 2030 and repaid $300.0 million of 4.5% Senior Notes in 2020.
- Agreed on January 8, 2021 to acquire Abel Pumps, L.P. and affiliates for $103.5 million in cash, expected to close in Q1 2021.
- Stockholder return index of $260.02 at 12/20 compared with $183.77 for the S&P 500 Index, both based on $100 at 12/15.
03—One dollar
Follow one dollar
Of each $1.00 of revenue in FY2020, Idex kept $0.16.
- Revenue$2.35B100.0%
- Cost of revenue−$1.32B56.3%
- Gross profit$1.03B43.7%
- Operating costs−$506.7M21.5%
- Operating income$520.7M22.1%
- Interest, other & tax−$142.9M6.1%
- Net income$377.8M16.1%
Where FY2020 revenue went
$2.35B- Cost of revenue: $1.32B, 56% of revenue
- SG&A: $494.9M, 21% of revenue
- Net income: $377.8M, 16% of revenue
- R&D: $48.2M, 2.0% of revenue
- Interest, other & tax: $142.9M, 6.1% of revenue
Kept 16% as net income
Full revenue history →04—Financials
Financial Highlights
Figures from 10-KFY2020filed February 25, 2021Financial Statements
FY2020 against FY2019
| Line item | FY2020FY2019 | Change |
|---|---|---|
| Revenue | $2.35B$2.49B | −5.7% |
| Cost of Revenue | $1.32B$1.37B | −3.3% |
| Gross Profit | $1.03B$1.13B | −8.7% |
| R&D Expenses | $48.20M$56.40M | −14.5% |
| SG&A Expenses | $494.90M$525.00M | −5.7% |
| Operating Income | $520.70M$579.00M | −10.1% |
| Interest Expense | $44.80M$44.30M | +1.1% |
| Net Income | $377.80M$425.50M | −11.2% |
| EPS (Basic) | $4.98$5.62 | −11.4% |
| EPS (Diluted) | $4.94$5.56 | −11.2% |
| Shares Outstanding (Basic) | 75.70M75.60M | +0.1% |
| Shares Outstanding (Diluted) | 76.40M76.50M | −0.1% |
05—Questions
Frequently Asked Questions
How did COVID-19 affect IDEX's 2020 results?
The filing says the pandemic materially reduced sales and profitability, with customers purchasing less from the onset through the second quarter of 2020. End markets improved beginning in the third quarter and continuing through the fourth quarter, and the company expects them to normalize to historical levels through 2021. Net sales in the second quarter were $561.2 million, down from $642.1 million in the second quarter of 2019.
Which segment performed best in 2020?
Health & Science Technologies was the strongest on operating income, rising 3% to $206.4 million with margin up 110 basis points to 23.0%, driven by price capture and cost savings. Fluid & Metering Technologies saw operating income fall 18% to $235.0 million, and Fire & Safety/Diversified Products fell 13% to $144.2 million.
How is IDEX positioned financially at the end of 2020?
The company reported total assets of $4,414.4 million, a current ratio of 4.2, and total equity of $2,540.3 million. Its total borrowings were $1,050.2 million, all fixed rate, and it had no balance outstanding under its $800 million revolving facility. Management believes it has sufficient cash and access to capital for at least the next twelve months.
What acquisitions did IDEX complete or announce?
In 2020 IDEX acquired Flow Management Devices for $121.2 million in cash and Qualtek for $1.9 million. In January 2021 it agreed to acquire Abel Pumps, L.P. and affiliates for $103.5 million in cash, which will be part of the Pumps platform within the Fluid & Metering Technologies segment.
What did IDEX do with its capital in 2020?
IDEX repurchased 876 thousand shares for $110.3 million and paid dividends of $151.8 million. It also received $44.6 million from stock option exercises. Remaining share repurchase authorization was $712.0 million as of December 31, 2020.
06—Continue